J De Greve
Overview
Explore the profile of J De Greve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joris S, Denys H, Collignon J, Rasschaert M, TKint de Roodenbeke D, Duhoux F, et al.
ESMO Open
. 2023 Oct;
8(6):102041.
PMID: 37852034
Background: The Belgian Precision initiative aims to maximize the implementation of tumor-agnostic next-generation sequencing in patients with advanced cancer and enhance access to molecularly guided treatment options. Academic tumor-agnostic basket...
2.
Thouvenin J, van Marcke C, Decoster L, Raicevic G, Punie K, Vandenbulcke M, et al.
ESMO Open
. 2022 Aug;
7(4):100524.
PMID: 35970014
PRECISION is an initiative from the Belgian Society of Medical Oncology (BSMO) in collaboration with several stakeholders, encompassing four programs that aim to boost genomic and clinical knowledge with the...
3.
Vergote I, Denys H, De Greve J, Gennigens C, Van de Vijver K, Kerger J, et al.
Facts Views Vis Obgyn
. 2020 Oct;
12(3):227-239.
PMID: 33123697
Most ovarian cancer patients are diagnosed only at advanced stages when survival outcomes are worse, andwhen therapeutic decisions might prove challenging. The fundamental treatment for women with ovarian cancerincludes debulking...
4.
Goossens M, De Brabander I, De Greve J, Van Ongeval C, Martens P, Van Limbergen E, et al.
BMC Cancer
. 2019 Oct;
19(1):1012.
PMID: 31660890
Background: We examined 15 years of key performance indicators (KPIs) of the population-based mammography screening programme (PMSP) in Flanders, Belgium. Methods: Individual screening data were linked to the national cancer...
5.
Gidron Y, De Couck M, Schallier D, De Greve J, Van Laethem J, Marechal R
J Immunol Res
. 2018 Jun;
2018:4874193.
PMID: 29854838
Background: The vagus nerve may slow tumor progression because it inhibits inflammation. This study examined the relationship between a new vagal neuroimmunomodulation (NIM) index and survival in fatal cancers. Method:...
6.
Decoster L, Kenis C, Schallier D, Vansteenkiste J, Nackaerts K, Vanacker L, et al.
Lung
. 2017 Jun;
195(5):619-626.
PMID: 28634893
Purpose: Older patients with lung cancer are a heterogeneous population making treatment decisions complex. This study aims to evaluate the value of geriatric assessment (GA) as well as the evolution...
7.
Horlait M, Leys M, De Greve J, Van Belle S
Ann Oncol
. 2016 Dec;
28(3):670-671.
PMID: 27993807
No abstract available.
8.
De Brakeleer S, De Greve J, Desmedt C, Joris S, Sotiriou C, Piccart M, et al.
Clin Genet
. 2015 May;
89(3):336-40.
PMID: 26010302
Triple-negative breast cancer (TNBC) accounts for 10-20% of all breast cancers (BCs), and conventional chemotherapy is the only effective systemic treatment. Germline BRCA1/2 mutations are found in approximately 15% of...
9.
Goossens M, van Hal G, van der Burg M, Kellen E, Van Herck K, De Greve J, et al.
Prev Med
. 2014 Dec;
69:280-6.
PMID: 25456812
Background: Mammographic screening may reduce breast cancer mortality by about 20%, provided participation is high and women screen regularly. We quantified independent risk factors for failing to rescreen and built...
10.
Chaib I, Karachaliou N, AlHusaini H, Sanchez-Ronco M, Drozdowskyj A, Sanchez J, et al.
Ann Oncol
. 2014 Aug;
25(11):2147-2155.
PMID: 25164908
Background: In a Spanish Lung Cancer Group (SLCG) phase II trial, the combination of BRCA1 and receptor-associated protein 80 (RAP80) expression was significantly associated with outcome in Caucasian patients with...